To advise the Commission on the safety and efficacy of medicines for used for the treatment and prevention of cardiovascular, diabetes and renal diseases.
Meeting dates for 2008
| January |
April |
June |
July |
October |
December |
| 31 |
3 |
4 |
31 |
2 |
3 |
Chair
*Professor Henry Dargie MB, ChB, FRCP, FESC
Consultant Cardiologist & Co-Director of CRI in Heart Failure, Glasgow University (Chair)
Members
Professor Richard Donnelly MD, PhD FRCP FRACP
Professor of Vascular Medicine, Derby City General Hospital & Nottingham University Graduate Medical School
Professor Paul N Durrington, BSc MD FRCP FRCPath FMedSci FAHA
Professor of Medicine, Department of Medicine, Manchester Royal Infirmary & University of Manchester
Dr J Colin Forfar B.Sc (Hons), MBChB, PhD, MD, MA, FRCP
Consultant Physician and Cardiologist, John Radcliffe Hospital, Oxford
Dr Michael D Gammage MB ChB, MD, FRCP (London), FESC
Reader in Cardiovascular Medicine and Honorary Consultant Cardiologist, University Hospital Birmingham
Dr Andrew Grace MB BS (Hons), PhD, FRCP FACC FESC
Consultant Cardiologist, Papworth Hospital, Cambridge & Senior Research Fellow, Dept of Biochemistry, Cambridge University
Professor Philip D Home B.A, D.Phil, M.A, B.M.,B.Ch, MRCP, D.M
Professor of Diabetic Medicine/Consultant Physician, Newcastle
Dr Michael J Stewart MB ChB, MD, FRCPE, FRCP
Consultant Cardiologist, James Crook University Hospital, Middlesbrough
Professor Allan D Struthers MD, FRCP(Glas), FRCPE, FRCP FESC FBPharmacolS
Professor of Cardiovascular Medicine and Therapeutics, Ninewells Hospital & Medical School, Dundee
Dr Solomon Tesfaye MB ChB, MD, FRCP
Consultant Physician and Diabetologist, Royal Hallamshire Hospital, Sheffield
Professor Abdel Meguid El Nahas CFM, PhD, FRCP
Professor of Nephrology/Consultant Renal Physician, Sheffield Kidney Institute, Northern General Hospital
* = Member of the Commission on Human Medicines